InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Kahn Barbara, Director. Insider active across 1 company, notably DEXCOM INC. Aggregated, 5 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €38k. History available since 20 May 2021. The latest transaction was filed on 18 May 2024 (Don). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Kahn Barbara
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
2,927 shares0Common StockSEC:0001093557-24-000096:0
2,927 shares@ US$0.0010.0% of flowCommon StockSEC:0001093557-23-000137:0
918 shares0Common StockSEC:0001093557-22-000119:0
100 shares@ US$428.55100.0% of flowCommon StockSEC:0001093557-22-000016:0
787 shares0Common StockSEC:0001093557-21-000145:0
5 of 5 declarations
About Kahn Barbara
Barbara Kahn is a Director at Dexcom Inc. As a board member, she contributes to the governance of the company and strategic decision-making. Her expertise in the healthcare sector is an asset for Dexcom.
